Collegium Pharmaceutical, Inc.COLLNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank50
3Y CAGR+3.6%
5Y CAGR-3.3%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+3.6%/yr
vs -4.3%/yr prior
5Y CAGR
-3.3%/yr
Recent acceleration
Acceleration
+7.9pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.88 | +28.4% |
| 2024 | 1.46 | -20.1% |
| 2023 | 1.83 | +8.3% |
| 2022 | 1.69 | -28.2% |
| 2021 | 2.36 | +6.0% |
| 2020 | 2.22 | -4.2% |
| 2019 | 2.32 | +15.3% |
| 2018 | 2.01 | -89.7% |
| 2017 | 19.62 | -91.1% |
| 2016 | 220.79 | - |